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Abstract
The signaling of Toll-like receptors (TLRs) is the host’s first line of defense against microbial invasion. The mitochondrion is
emerging as a critical platform for antiviral signal transduction. The regulatory role of mitochondria for TLR signaling
remains to be explored. Here, we show that the mitochondrial outer-membrane protein MARCH5 positively regulates TLR7
signaling. Ectopic expression or knockdown of MARCH5 enhances or impairs NF-kB-mediated gene expression, respectively.
MARCH5 interacts specifically with TANK, and this interaction is enhanced by R837 stimulation. MARCH5 catalyzes the K63-
linked poly-ubiquitination of TANK on its Lysines 229, 233, 280, 302 and 306, thus impairing the ability of TANK to inhibit
TRAF6. Mislocalization of MARCH5 abolishes its action on TANK, revealing the critical role of mitochondria in modulating
innate immunity. Arguably, this represents the first study linking mitochondria to TLR signaling.
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Introduction
Germline-encoded pattern recognition receptors (PRRs) play
pivotal roles in sensing a wide range of invading pathogens, via
recognizing conserved microbial signature molecules (PAMPs,
pathogen associated molecular patterns). As molecular switches that
register microbial infection, these receptors promptly initiate innate
immune responses and subsequently prime the adaptive immune
system to eliminate the pathogens [1,2,3]. Toll-like receptors (TLRs)
areonemajorclassofPRRs.Todate,13membersoftheTLRfamily
have been identified in mammals, of which TLR4 recognizes
lipopolysaccharide (LPS) from gram-negative bacteria, and TLR7
senses viral single strand RNA (ssRNA) [2]. Both TLR4 and TLR7
can induce the robust expression of proinflammatory cytokines and
type I interferons (IFNs).
Recent years have witnessed an incredible gain in knowledge
about the TLR signaling cascades. For example, in response to
stimuli, TLR7 triggers the recruitment of MyD88 via its Toll-
interleukin 1 receptor (IL-1R) homology (TIR) domain, which in
turn recruits IRAK4 and IRAK1. IRAK4 then activates IRAK-1
by phosphorylation. As a result, the IRAKs dissociate from
MyD88 and interact with TRAF6, a ubiquitin E3 ligase [4,5,6].
Together with Ubc13 and Uev1A, TRAF6 catalyzes the formation
of lysine 63 (K63)-linked poly-ubiquitin chains, which serve as the
anchoring platform for a protein complex that includes TRAF6,
TRAF3, IKKa, and IRF7, leading ultimately to the induction of
type I IFNs and ISGs (interferon-inducible genes) [7,8]. In the
meantime, TAK1 is recruited to the TRAF6 protein complex,
resulting in the activation of NF-kB and the induction of
proinflammatory cytokines [9].
Given the critical roles of TLR signaling in innate immunity,
multiple layers of stringent regulations are employed to ensure that
the strength and duration of the TLR signal is appropriate for any
given immune response. Several proteins have been demonstrated
to modulate the TLR signaling pathways, such as A20, CYLD,
IRAKM, ST2, SIGIRR and SOCS1 [10,11,12,13,14,15,16].
Importantly, TANK (also called I-TRAF) was initially character-
ized as a TRAF binding protein [17,18]. Recently, the in vivo
function of TANK has been further clarified. Surprisingly, TANK
is not essential for interferon induction and instead is a potent
negative regulator for TLR-mediated induction of proinflamma-
tory cytokines [19]. How TANK specifically modulates NF-kB
signaling upon TLR activation remains to be determined.
Mitochondria are rapidly emerging as important platforms for
intracellular antiviral signaling. MAVS (also known as IPS-1/
VISA/Cardif) is the first mitochondrial protein identified as a
critical component of the RIG-I/MDA5 signaling pathway [20].
Following this, several more mitochondrial proteins have been
implicated in modulating this same antiviral signaling pathway,
such as NLRX1, STING (also known as MITA) and MFN1
[21,22,23,24]. We have recently discovered that the mitochondrial
outer-membrane receptor TOM70 mediates IRF3 activation
downstream of MAVS [25,26,27].
Notably, whether any mitochondrial protein(s) can regulate
TLR signaling remains an open question. It was recently reported
that two ubiquitin E3 ligases constitutively express on mitochon-
dria, MARCH5/MITOL/RNF153 and GIDE (Growth Inhibi-
tion and Death E3 Ligase). MARCH family proteins are
characterized by harboring a RING-CH domain and multiple
trans-membrane domains. Interestingly, many RING proteins
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(MARCH1, MARCH8) appear to either directly or indirectly
modulate immune functions by controlling the surface turnover of
immune regulatory molecules on the plasma membrane [28].
MARCH5 (also named MARCH-V/MITOL/RNF153) was
recently identified as a new member in the MARCH family
[29,30]. Preliminary characterization uncovered MARCH5 as a
novel mitochondrial protein. Until recently, little was known about
the potential function of MARCH5. Several recent studies have
determined that MARCH5 can potentially modulate mitochon-
drial fission and the morphology of mitochondria [29,30,31].
In this study, we reveal that the mitochondrial protein
MARCH5 is a novel E3 ubiquitin ligase and a positive regulator
for TLR7 signaling. MARCH5 catalyzes the K63-linked poly-
ubiquitination of TANK on its Lysines 229, 233, 280, 302 and
306. This modification releases the inhibitory effects of TANK
toward TRAF6. Consequently, ectopic expression or knockdown
of MARCH5 enhances or impairs NF-kB-mediated proinflamma-
tory gene expression, respectively, in response to TLR7 activation.
Interestingly, the localization of MARCH5 on mitochondria is
indispensable for its regulatory action, demonstrating a new role
for mitochondria in the proinflammatory response. To our
knowledge, this is the first report that links mitochondria to
TLR signaling.
Results
Identification of MARCH5 as a new regulator of TLR
signaling
Poly-ubiquitination is a major mechanism for regulating innate
immunity. Because the mitochondrial protein MAVS was recently
reported to be modified by both K48- and K63- linked poly-
ubiquitin [32,33,34], we speculated whether these post-transla-
tional modifications were mediated by any mitochondrial
ubiquitin E3 ligase. We noticed that MARCH5/MITOL/
RNF153 is constitutively expressed in mitochondria and contains
a RING domain, a signature of ubiquitin E3 ligases. To explore
the potential role of MARCH5, we screened effective siRNAs
against MARCH5 (MARCH5 siRNA 369 and MARCH5 siRNA
582 for mouse, hMARCH5 siRNA for human) (Fig. 1A, B). It was
found that knockdown of endogenous MARCH5 did not affect
kB-luciferase and PRDIII-I-luciferase reporters (responsive to NF-
kB and IRF3/7 activation, respectively) stimulated by Sendai virus
or transfected poly(I:C). Consistently, silencing of MARCH5
produced no effect on RIG-I- or MAVS-mediated activation of
kB-luciferase or IFN-b-luciferase reporters (Fig. 1 E, F). Nor did
MARCH5 produce any effect on MAVS poly-ubiquitination (Fig.
S7). These indicate that MARCH5 is dispensable for RIG-I/
MDA5 signaling.
Surprisingly, activation of kB-luciferase reporter was apparently
impaired upon MARCH5 depletion in response to TLR3, TLR7
or TLR4 signaling in Raw264.7 cells when stimulated with
extracellular poly(I:C), imiquimod (R837), Loxoribine or LPS,
respectively (Fig. 1C). Notably, the impairment was more
significant for TLR7 and TLR4 than for TLR3. Interestingly,
activation of the PRDIII-I-luciferase reporter was barely modu-
lated by MARCH5 under these stimuli (Fig. 1D). Apparently,
MARCH5 could modulate TRIF-, MyD88- or IRAK1-induced
kB-luciferase activity (Fig. 1E). These data suggest that MARCH5
is possibly critical for NF-kB activation downstream of TLRs but is
dispensable for IRF3/7 activation.
In addition, confocal microscopy and fractionation analysis
confirmed that MARCH5 was predominantly expressed on
mitochondria (Fig. 1G, H). R837 and LPS stimulation did not
influence the expression of MARCH5 (Fig. 1I, J).
MARCH5 potentiates TLR7-mediated NF-kB activation
To substantiate these observations, the introduction of wild-type
(WT) MARCH5 into Raw264.7 cells potentiated the activation of
the kB-luciferase reporter upon R837 or LPS stimulation (Fig. 2A).
In contrast, the activation of PRDIII-I-luciferase reporter was
unaffected by ectopic expression of MARCH5 under the same
stimuli (Fig. 2B).
Furthermore, we investigated whether MARCH5 modulated
the expression of NF-kB-responsive genes (IL6 and TNFa)
induced by R837 using the assays of qPCR (quantitative PCR)
and ELISA (enzyme-linked immunosorbent assay). As shown in
Fig. 2C and Fig. S1A, MARCH5 displayed synergic effects on the
induction of NF-kB-responsive genes. Similarly, MARCH5
synergized NF-kB activation stimulated by LPS (Fig. 2D and
Fig. S1B). However, this did not apply to the induction of ISG15
mRNA, which is regulated by IRF3/7 (Fig. 2C, D).
To make the experiments more physiologically relevant, we
examined whether MARCH5 regulated NF-kB-induced gene
expression in primary cells. Consistently, ectopic expression of
MARCH5 markedly potentiated the expression of endogenous
NF-kB-responsive genes (IL6 and TNFa) induced by R837 in
BMDCs (bone marrow-derived dendritic cells) (Fig. 2E).
To explore the potential role of MARCH5 RING domain, we
generated MARCH5 C2A (C65/68S) and MARCH5 DRING
(D12-70 a.a.), both of which abrogated the potential E3 ubiquitin
ligase activity of MARCH5 (Fig. S5A). As shown in Fig. 2A,
exogenous expression of MARCH5 C2A and MARCH5 DRING
failed to synergize the induction of NF-kB-responsive reporter
upon R837 or LPS stimulation. Consistently, the expression of
NF-kB-responsive genes (IL6 and TNFa) induced by R837 or LPS
was barely affected when MARCH5 C2A or MARCH5 DRING
was ectopically expressed (Fig. 2C, D, E and Fig. S1A, B).
Apparently, ectopic expression of MARCH5 has no effect on the
cell cycle or apoptosis (Fig. S2). Taken together, these data suggest
that MARCH5 specifically potentiates TLR signaling, and this
effect is dependent on its E3 ubiquitin ligase activity.
Knockdown of MARCH5 attenuates TLR7-mediated
NF-kB activation
Next, we explored the effect of MARCH5 knockdown on the
expression of endogenous NF-kB-responsive genes, stimulated by
R837 or LPS in Raw264.7 cells. As expected, MARCH5
knockdown attenuated the induction of NF-kB-responsive genes
Author Summary
In 2005, MAVS was characterized as the critical adaptor
protein for the signal transduction of RIG-I-like receptors
(RLRs). This provided the first link between mitochondria
and the intracellular antiviral defense system. From then
on, exploring the potential functions of novel mitochon-
drial proteins in microbe-host interactions became a
rapidly expanding frontier. Notably, it remains unknown
whether mitochondrial proteins can directly regulate TLR
signaling. Here, we demonstrate that the mitochondrial
protein MARCH5 positively modulates TLR7 signaling. Our
study reveals that MARCH5 is a novel E3 ubiquitin ligase
and catalyzes the K63-linked poly-ubiquitination of TANK.
This modification releases the inhibitory effects of TANK on
TRAF6. Arguably, this represents the first study linking
mitochondria to TLR signaling, shedding new light on the
role of mitochondria in the proinflammatory response.
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(ISG15) (Fig. 3A, B and Fig. S1C, D).
We further investigated the function of MARCH5 in primary
cells. BMDCs were transfected with siRNAs against MARCH5,
followed by R837 or LPS stimulation. Consistently, knockdown of
MARCH5 markedly attenuated the expression of endogenous NF-
kB-responsive genes in BMDCs (Fig. 3C, D).
To rule out potential off-target effects of the MARCH5 siRNA,
we generated several RNA interference (RNAi)-resistant HA-
MARCH5 constructs, namely rMARCH5 WT, rMARCH5 C2A
and rMARCH5 DRING, in which silent mutations were
introduced into the sequence targeted by the siRNA without
changing the amino acid sequence of the corresponding proteins.
Raw264.7 cells were first transfected with control or MARCH5
siRNA followed by transfection of control or indicated rMARCH5
plasmids, respectively. Then the induction of IL6 mRNA was
measured after R837 or LPS stimulation. As shown in Fig. 3E and
Fig. 3F, the induction of IL6 was restored by rMARCH5 WT, but
not rescued by rMARCH5 C2A and rMARCH5 DRING.
Apparently, knockdown of MARCH5 influences neither the cell
cycle nor apoptosis (Fig. S3). Collectively, these results indicate
that MARCH5 is a positive regulator of TLR-mediated NF-kB
activation.
MARCH5 specifically interacts with TANK
To address the mechanism of MARCH5 action, we explored
whether MARCH5 could interact with TLR signaling proteins. A
co-immunoprecipitation assay revealed that MARCH5 interacted
with TRAF6, TANK and MAVS but did not interact with
TRAF3, NEMO or RIG-I (Fig. 4A). Interestingly, MARCH5 did
not catalyze the ubiquitination of any of the indicated proteins
except TANK (Fig. S7). Therefore, we further probed the
interaction between MARCH5 and TANK.
As shown in Fig. 4B, HA-MARCH5 co-immunoprecipitated
with Flag-TANK, but not with control IgG. Similarly, Flag-
TANK co-immunoprecipitated with HA-MARCH5, but not with
control IgG (Fig. 4C). Notably, HA-MARCH5 C2A and HA-
MARCH5 DRING could interact with Flag-TANK as well
(Fig. 4B, C). We subsequently confirmed the endogenous
interaction between MARCH5 and TANK (Fig. 4D). Interesting-
ly, the endogenous interaction between MARCH5 and TANK
was enhanced by R837 stimulation (Fig. 4D).
A series of Flag-TANK deletion mutants were generated and
individually transfected into HEK293T cells along with HA-
MARCH5. It was observed that the C terminal region of TANK
(amino acids 190 to 413) mediated this interaction (Fig. 4E).
We went on to investigate the sub-cellular localization of
endogenous TANK. Confocal microscopy revealed that TANK
displayed a punctate staining pattern in the cytoplasm of resting
cells. Interestingly, TANK partially co-localized with mitochon-
dria upon R837 or LPS stimulation, suggesting that TANK was
dynamically recruited to mitochondria in response to these stimuli
(Fig. S4). Collectively, these results indicate that MARCH5 is a
new TANK binding protein in vivo.
MARCH5 catalyzes K63-linked poly-ubiquitination of
TANK
A couple of recent studies implicated MARCH5 as an E3
ubiquitin ligase that catalyzes the ubiquitination of hFis1 and
Drp1, causing their degradation [31]. In vitro ubiquitination assays
confirmed that the MARCH5 RING domain can catalyze the
formation of both K48- and K63-linked polyUb chains, whereas
MARCH5-C2A or MARCH5 DRING cannot (Fig. S5).
Our above data revealed the importance of this E3 ubiquitin
ligase activity for regulating TLR signaling (Fig. 2). Therefore, we
wondered whether TANK was a new ubiquitination target of
MARCH5. In HEK293T cells, Flag-TANK and His-Ubiquitin
was co-transfected with MARCH5 (WT), MARCH5 C2A,
MARCH5 DRING or GIDE, respectively. The cell lysates were
subjected to immunoprecipitation of Flag-TANK (Fig. 5A) or Ni-
NTA pulldown of His-Ubiquitin (Fig. 5B). Then the precipitates
were probed with indicated antibodies as seen in Fig. 5A and
Fig. 5B. Notably, TANK was markedly poly-ubiquitinated in the
presence of MARCH5 (WT). In contrast, MARCH5 C2A,
MARCH5 DRING and GIDE could not catalyze ubiquitination
of TANK (Fig. 5A, B). In addition, ectopic-expression of
MARCH5 enhanced poly-ubiquitination of TANK in Raw264.7
cells upon R837 stimulation, whereas MARCH5 C2A had no
such effect (Fig. 5C). Consistently, knockdown of MARCH5
attenuated this poly-ubiquitination of endogenous TANK
(Fig. 5D). These data indicate that MARCH5 is a novel E3
ubiquitin ligase for TANK.
It was recently reported that TANK was modified by K63-
linked polyubiquitination via (an) unknown E3 ubiquitin ligase(s)
[35]. We further tested whether MARCH5 could fulfill this
function. A panel of ubiquitin mutants was employed including
those containing a point mutation at lysine 48 (K48R) or 63
(K63R) or lacking all lysines except K48 (K48-only ubiquitin) or
K63 (K63-only ubiquitin) (Fig. 5E upper panel). As expected,
MARCH5 catalyzed TANK poly-ubiquitination in the presence of
wild type ubiquitin. Importantly, TANK was poly-ubiquitinated as
well when using the K48R or K63 ubiquitin whereas poly-
ubiquitination of TANK disappeared when using the K63R or
K48 ubiquitin (Fig. 5E lower panel). This firmly established that
MARCH5 facilitated the synthesis of K63- rather than K48-
linked poly-ubiquitin chains onto TANK.
Figure 1. Identification of MARCH5 in TLR7 signaling pathway. A, HEK293T cells were transfected with HA-MARCH5 and then treated with
the nonspecific control (N.C.) or MARCH5 siRNA (left panel). Raw264.7 cells were transfected with the negative control (N.C.) or MARCH5 siRNA (right
panel). Cell lysates were immunoblotted with the indicated antibodies. B, HEK293T cells were transfected with HA-hMARCH5 and then treated with
the nonspecific control (N.C.) or hMARCH5 siRNA (left panel). HEK293T cells were transfected with the negative control (N.C.) or hMARCH5 siRNA
(right panel). Cell lysates were immunoblotted with the indicated antibodies. C and D, the nonspecific control (N.C.) or MARCH5 siRNA were
transfected into Raw264.7 cells with NF-kB (C) or PRDIII-I reporter plasmids (D), respectively. Forty-eight hours after transfection, cells were stimulated
with poly(I:C) (2 mg/ml, transfected), poly(I:C) (50 mg/ml, added to the culture medium), R837 (10 mg/ml), Loxoribine (50 mM) or LPS (100 ng/ml) for
6 h before luciferase assays were performed. A pTK-Renilla reporter was used to normalize data. E and F, the nonspecific control (N.C.) or hMARCH5
siRNA were transfected into HEK293T cells together with NF-kB (E) or IFNb reporter plasmids (F), respectively. Forty-eight hours after transfection,
cells were transfected again with RIG-I, MAVS, TRIF, MyD88 or IRAK1 for 16 h before luciferase assays were performed. A pTK-Renilla reporter was
used to normalize data. G, HA-MARCH5 was transfected into HEK293T cells (upper panel) or HeLa cells (lower panel), which were then stained with an
anti-HA antibody and imaged by confocal microscopy. The mitochondria were stained with MitoTracker. H, HEK293T cells were fractionated as shown
in diagram (top panel). The corresponding fractions were analyzed by immunoblotting with the indicated antibodies (bottom panel). I and J,
Raw264.7 cells were stimulated with R837 (10 mg/ml) or LPS (100 ng/ml), respectively, for the indicated time periods. The mRNA level of MARCH5 was
measured by quantitative PCR (I), and the protein level of MARCH5 was measured by immunoblotting with an anti-MARCH5 antibody (J). Data from
C–F and I are presented as means 6 S.D. from three independent experiments. *, P,0.05; **, P,0.01.
doi:10.1371/journal.ppat.1002057.g001
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PLoS Pathogens | www.plospathogens.org 4 May 2011 | Volume 7 | Issue 5 | e1002057Figure 2. MARCH5 synergizes TLR7- induced NF-kB activation. A and B, Equal amounts of the indicated Myc-tagged MARCH5 constructs
were transfected into Raw264.7 cells together with NF-kB (A) or PRDIII-I reporter plasmids (B). Twenty-four hours after transfection, cells were
stimulated with R837 (10 mg/ml) or LPS (100 ng/ml) for 6 h before luciferase assays were performed. C and D, induction of IL6, TNFa, and ISG15
mRNA by R837 (C) or LPS (D) stimulation in the presence of the indicated plasmids in RAW264.7 cells were measured by quantitative PCR. E, BMDCs
(bone marrow-derived dendritic cells) were transfected with the indicated plasmids and then stimulated by R837 (10 mg/ml). Induction of IL6, TNFa,
and ISG15 mRNAs was measured by qPCR. Data from A–E are presented as means 6 S.D. from three independent experiments. *, P,0.05; **, P,0.01.
WT, MARCH5 wild type; C2A, MARCH5 C65, 68A mutant; and DR, MARCH5 RING domain deletion mutant.
doi:10.1371/journal.ppat.1002057.g002
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PLoS Pathogens | www.plospathogens.org 5 May 2011 | Volume 7 | Issue 5 | e1002057Figure 3. Knockdown of MARCH5 impairs TLR7- induced NF-kB activation. A and B, The indicated siRNAs were transfected into Raw264.7
cells. Induction of IL6, TNFa, and ISG15 mRNA was measured by quantitative PCR after R837 (10 mg/ml) (A) or LPS (100 ng/ml) (B) stimulation. C and D,
The indicated siRNAs were transfected into BMDCs. Induction of IL6, TNFa, and ISG15 mRNA was measured by quantitative PCR after R837 (10 mg/ml)
(C) or LPS (100 ng/ml) (D) stimulation. E and F, Raw264.7 cells were transfected with the negative control (N.C.) or MARCH5 siRNA and then rescued with
the indicated siRNA-resistant MARCH5 constructs. After R837 (10 mg/ml) (E) or LPS (100 ng/ml) (F) stimulation, induction of IL6 mRNA was measured by
quantitative PCR. Data in A–F are presented as means 6 S.D. from three independent experiments. *, P,0.05; **, P,0.01.
doi:10.1371/journal.ppat.1002057.g003
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PLoS Pathogens | www.plospathogens.org 6 May 2011 | Volume 7 | Issue 5 | e1002057Figure 4. MARCH5 interacts with TANK. A, The indicated Flag tagged protein constructs were individually transfected into HEK293T cells along
with HA-MARCH5. Then, equal amounts of cell lysates were immunoprecipitated with an anti-Flag antibody. The immunoprecipitates were
immunoblotted with an anti-HA antibody. B, HEK293T cells were cotransfected with the indicated constructs. Then, equal amounts of cell lysates
were immunoprecipitated (IP) with anti-IgG or anti-Flag antibodies. The immunoprecipitates were immunoblotted with an anti-HA antibody.
C, HEK293T cells were cotransfected with the indicated constructs. Then, equal amounts of cell lysates were immunoprecipitated with anti-IgG or
anti-HA antibodies. The immunoprecipitates were immunoblotted with an anti-Flag antibody. D, After mock or R837 (10 mg/ml) stimulation, lysates
MARCH5 Negatively Regulates TANK on Mitochondria
PLoS Pathogens | www.plospathogens.org 7 May 2011 | Volume 7 | Issue 5 | e1002057To identify the potential ubiquitination sites on TANK, we
carried out a systematic lysine (K) to arginine (R) mutation
scanning. It was observed that ubiquitination of the TANK(5M)
mutant was markedly impaired (Fig. 5F). Notably, the TANK(5M)
mutant could interact with MARCH5 as well as wild-type TANK
(Fig. S6), indicating that these five lysines, 229, 233, 280, 302 and
306, were the major ubiquitination sites on TANK. Consistently,
ectopic expression or knockdown of MARCH5 apparently did not
affect the stability of endogenous TANK (Fig. 5G, H).
MARCH5 modulates TRAF6 auto-ubiquitination through
TANK
Recently, TANK was found to negatively regulate TLR-mediated
induction of pro-inflammatory cytokines [19]. We confirmed this
observation in Raw264.7 cells, i.e., knockdown of TANK resulted in
augmented cytokine production (IL6 and TNFa) in response to R837
stimulation (Fig. 6A). As TRAF6 is auto-ubiquitinated in response to
TLR stimuli, we tested whether TANK influenced the auto-
ubiquitination of TRAF6. Interestingly, R837-induced TRAF6
auto-ubiquitination was enhanced upon endogenous TANK deple-
tion (Fig. 6B). This indicated that TANK inhibited NF-kB activation
by suppressing TRAF6 auto-ubiquitination.
We went on to address whether TANK ubiquitination could
release its inhibitory effects toward TRAF6. Raw264.7 cells were
transfected with control or MARCH5 plasmids followed by R837
stimulation. Intriguingly, TRAF6 auto-ubiquitination was en-
hanced in the presence of the wild type MARCH5 (Fig. 6C). In
contrast, the ubiquitination of TRAF6 was not affected when
MARCH5 C2A was introduced (Fig. 6C).
Reciprocally, knockdown of MARCH5 inhibited the ubiquiti-
nation of TRAF6 (Fig. 6D). Notably, suppression of TRAF6
ubiquitination caused by MARCH5 knockdown could be reversed
by simultaneously knocking down TANK, suggesting that
MARCH5 regulated the auto-ubiquitination of TRAF6 through
TANK. This was further supported by probing TLR7-mediated
gene expression (IL6 and TNFa) when knocking down TANK and
MARCH5 at the same time (Fig. 6E). Taken together, these data
indicate that MARCH5 potentiates TLR7 signaling by releasing
the inhibitory effects of TANK toward TRAF6.
Mislocalization of MARCH5 impairs its function
To determine the importance of mitochondrial localization for
MARCH5 function, we generated two mislocalization mutants of
MARCH5. MARCH5 CAAX was constructed by replacing its C-
terminal transmembrane domain with a targeting sequence to the
plasma membrane, and MARCH5 NLS was constructed by
replacing the same transmembrane domain with a nuclear
localization sequence (Fig. 7A). As expected, MARCH5 CAAX
and MARCH5 NLS were targeted to the plasma membrane and
nucleus, respectively (Fig. 7B middle and lower panel). Interestingly,
MARCH5 CAAX and MARCH5 NLS failed to interact with
TANK, whereas the MARCH5-DM, the C-terminal transmem-
brane domain truncation, could still bind TANK (Fig. 7C).
Corroborating the activity of the mislocalization mutants, neither
MARCH5 CAAX nor MARCH5 NLS could catalyze the poly-
ubiquitination of TANK (Fig. 7D, E). Furthermore, neither
MARCH5 CAAX nor MARCH5 NLS could potentiate the
expression of IL6 or TNFa induced by R837 or LPS (Fig. 7F, G).
Collectively, these data indicate that mitochondrial localization of
MARCH5isessentialforitsregulatoryfunctionininnateimmunity.
Discussion
A new paradigm has been established in the past decade,
revealing how Toll-like receptors (TLRs) detect a wide range of
pathogens and then initiate immediate host defenses. As a result,
cytokines and chemokines are induced to mobilize immune cells
for controlling and eliminating pathological infections. Given that
the TLR signal transduction cascade is the first line of the host
defense against pathogens, they are subjected to multiple layers of
positive and negative regulations. Herein, we characterize the
mitochondrial protein MARCH5 as an essential and positive
modulator of TLR7 signaling.
In this study, several lines of evidence substantiate the novel
function of MARCH5 in TLR7 signaling. First, exogenous
expression of MARCH5 potentiated the induction of NF-kB
responsive genes upon R837 stimulation, but not the induction of
IRF3/7 responsive genes. Second, knockdown of MARCH5
unequivocally resulted in the reduction of NF-kB-mediated gene
expression, and this attenuation was rescued by exogenously
expressing a siRNA-resistant rMARCH5. Third, MARCH5
interacted with TANK, a negative regulator of TLR7 signaling.
Interestingly, TANK could partially co-localize to mitochondria in
response to TLR7 stimulation. This interaction was increased
upon R837 challenge, suggesting that the interaction was transient
and dynamic. Fourth, knockdown of TANK impaired the ability
of MARCH5 to potentiate TLR7 signaling.
Previous in vitro studies suggested that TANK positively
regulates TBK1 and IKKe-mediated production of type I
interferon [36]. However, analysis of TANK2/2 mice indicated
that TANK is not essential for the induction of type I interferon
downstream of RIG-I/MDA5 or TRIF [19]. Further analysis
revealed that TANK is critical for the negative regulation of
canonical NF-kB activation via suppression of TRAF6 auto-
ubiquitination [19]. The underlying mechanism is still not clear.
Ubiquitination is an effective mechanism to regulate TLR
signaling pathways. E3 ubiquitin ligases (Nrdp1, A20) and de-
ubiquitinases (DUBA, CYLD, and A20) have been demonstrated
as positive or negative modulators of these pathways. Nrdp1
‘preferentially’ promotes TLR-mediated production of type I
interferon [37]. A20 and CYLD ‘preferentially’ terminate TLR-
induced activation of NF-kB by de-ubiquitinating their substrates,
such as RIP1, TRAF6, TAK1, NEMO and so on [15,16]. DUBA
interacts with and de-ubiquitinates TRAF3, thereby attenuating
TLR-dependent and TLR-independent antiviral responses [38].
K48-linked poly-ubiquitin chains usually target substrates for
proteasome degradation, whereas K63-linked poly-ubiquitin
chains usually regulate substrate activity but do not promote
effective degradation. Gatot et al. previously reported that TANK
is subjected to lipopolysaccharide mediated K63-linked poly-
ubiquitination [35]. However, the identity of the relevant E3
ubiquitin ligase and the functional consequence of TANK poly-
ubiquitination remained to be revealed. In this study, we showed
that ectopic expression of MARCH5 enhanced poly-ubiquitina-
tion of TANK after R837 stimulation, whereas knockdown of
MARCH5 attenuated this poly-ubiquitination. Wild type
from Raw264.7 cells were immunoprecipitated with anti-TANK antibody or anti-IgG and then immunoblotted with an anti-MARCH5 antibody. E,
Schematic diagram of TANK and its truncation mutants (right) (TIM, TRAF-interaction motif). Flag-TANK mutants were individually transfected into
HEK293T cells along with HA-MARCH5. The cell lysates were immunoprecipitated with an anti-Flag antibody and then immunoblotted with the
indicated antibodies (left).
doi:10.1371/journal.ppat.1002057.g004
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PLoS Pathogens | www.plospathogens.org 8 May 2011 | Volume 7 | Issue 5 | e1002057Figure 5. MARCH5 catalyzes K63-linked poly-ubiquitination of TANK. A and B, HEK293T cells were transfected with the indicated plasmids.
Twenty-four hours after transfection, cell lysates were subjected to immunoprecipitation (A) or Ni-NTA pulldown (Ni PD) (B) and then immunoblotted
with the indicated antibodies. C, Raw264.7 cells were transfected with the indicated plasmids and then stimulated with R837 (10 mg/ml). Cell lysates
were subjected to immunoprecipitation and then immunoblotted with the indicated antibodies. D, Raw264.7 cells were transfected with the
indicated siRNAs. After R837 stimulation, cell lysates were subjected to immunoprecipitation and immunoblotted with the indicated antibodies.
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PLoS Pathogens | www.plospathogens.org 9 May 2011 | Volume 7 | Issue 5 | e1002057MARCH5 catalyzed the K63-linked poly-ubiquitination of
TANK on its Lysines 229, 233, 280, 302 and 306. Neither
MARCH5 C2A nor MARCH5 DRING could synergize the
activation of NF-kB, stimulated by R837. The siRNA-resistant
mutants (rMARCH5 C2A or rMARCH5 DRING) could not
rescue the NF-kB activation in MARCH5 knockdown cells. In
addition, TANK per se could interfere with TRAF6 auto-
ubiquitination.
The in vitro ubiquitination assay revealed that MARCH5 could
catalyze the formation of both K48- and K63-linked polyUb
chains. This is somewhat unexpected given that MARCH5
mediates only K63-linked polyubiquitination of TANK in
transfected cells. One possible explanation for this discrepancy is
that additional cofactors may exist in vivo to guide the reaction of
MARCH5 in favor of the K63 linkage. Indeed, we have previously
shown that TRAF6 only catalyzes the formation of K63-linked
polyUb chains in vivo, which positively regulate the NF-kB
signaling pathway [39]. Similar to what is observed for MARCH5,
TRAF6 could facilitate the assembly of both K48- and K63-linked
polyUb chains in vitro [40]. Recent mechanistic studies of polyUb
chain formation revealed that additional proteins were involved in
the determination of polyUb linkage [41,42]. Strikingly, the
NEMO protein is reported to be modified in vivo by linear-, K27-
and K63-linked polyUb chains under different physiological
conditions [43]. It is thus a great challenge to monitor the
dynamic formation of various polyUb chains of different linkages
and determine their cognate functional consequences. Currently,
we are trying to use the RNAi approach to screen for potential
cofactor(s) of MARCH5. Hopefully, this will shed new light on
how MARCH5 catalyzes the formation of K63-linked polyUb
chains in vivo. Taken together, we propose that MARCH5 is an
authentic E3 ubiquitin ligase and catalyzes K63-linked poly-
ubiquitination of TANK. MARCH5 modulates TLR7 signaling
via releasing the inhibitory action of TANK toward TRAF6.
We speculate that MARCH5 potentiates TLR7 and TLR4
signaling via a similar mechanism. Interestingly, this regulatory
function was less potent for TLR4 signaling, probably due to the
observation that other TRAFs could partially mediate TLR4
signaling to NF-kB activation [44]. Consistently, it appears that
MARCH5 does not influence the activation of IRF3/7, since
TANK displays no regulatory role toward TRAF3 [19].
Interestingly, mislocalization of MARCH5 to either the plasma
membrane or the nucleus abolishes its function toward TLR7
signaling. An increasing number of sub-cellular organelles are
functionally connected to the anti-microbial defense system. For
example, it has been proposed that endosomes and lysosomes
contain TLR3/7/8/9 and probably TLR4 [45]. Recognition of
PAMPs by TLRs actually takes place inside these intracellular
membrane structures, instead of on the plasma membrane. In
addition, the endoplasmic reticulum (ER) plays an active role
during the transport of TLRs to their appropriate locations.
Unexpectedly, mitochondria have recently been uncovered as a
new platform for sensing intracellular virus infections. Notably, the
existence of cross-talk between TLR signaling and mitochondrial
proteins remained unknown. Arguably, our current study reveals
the first mitochondrial protein to positively regulate TLR
signaling. Because mitochondria and the ER are physically
connected, we expect that future investigations will uncover more
intricate cross-talk between them during TLR signaling.
MARCH family proteins contain a RING finger domain and
some trans-membrane motifs. Notably, many of the 11 mamma-
lian MARCH proteins have been implicated in modulating
immune functions, either directly or indirectly. MARCH8 (also
known as c-MIR, cellular modifier of immune response) was
demonstrated to specifically catalyze B7.2 ubiquitination and its
subsequent lysosomal degradation. In addition, both MARCH8
and MARCH1 negatively modulate the expression of CD95 (Fas),
TfR (transferrin receptor) and MHC class II [28]. MARCH4 and
MARCH9 influence antigen presentation by MHC class I
molecules. Furthermore, ectopic-expression of MARCH9 leads
to the down-regulation of surface ICAM1, a co-stimulatory
molecule for T and B cells [28]. It will be intriguing to examine
whether other MARCH family proteins play a critical role in
immune regulation.
Materials and Methods
Plasmids
MARCH5, TANK, GIDE, TRAF6, TRAF3, NEMO, MAVS
and RIG-I cDNAs were amplified by PCR from thymus cDNA
library (Clontech) and subsequently cloned into mammalian
expression vectors as indicated. His-Ub and the reporter plasmids
(kB-luciferase and PRDIII-I-luciferase reporters) have been
described previously [46]. All point mutations were introduced
by using a QuickChange XL site-directed mutagenesis method
(Stratagene). All constructs were confirmed by sequencing.
Reagents
Rabbit polyclonal anti-MARCH5 antibody was a gift from
Shigehisa Hirose (Tokyo Institute of Technology, Midori-ku,
Yokohama, Japan). Anti-TANK antibodies were raised in rabbits
against full-length mouse TANK and affinity purified using an
antigen column. Other commercially available antibodies and
reagents used were as follows: HA, Myc, Tom20 and Ub
antibodies were purchased from Santa Cruz Biotechnology, Inc.
Tubulin, Flag and b-actin antibodies were obtained from Sigma-
Aldrich. R837 and lipopolysaccharide were purchased from
Sigma-Aldrich.
Cell culture and transfection
HEK293T and RAW264.7 cells were cultured using DMEM
(Invitrogen) plus 10% FBS (Hyclone), supplemented with 1%
penicillin-streptomycin (Invitrogen). The procedure for generating
BMDCs (bone marrow-derived dendritic cells) has been described
previously [26]. Lipofectamine (Invitrogen) was used for transient
transfection of HEK293T Cells. RAW264.7 cells were transfected
with Nucleofector (Amaxa). Small interference RNA was trans-
fected with Lipofectamine 2000 (Invitrogen) according to the
manufacturer’s instructions.
Immuno-precipitation analysis and Immuno-blot analysis
For immuno-precipitation analysis, cells were lysed in TBS
buffer (50 mM Tris-Cl pH 7.4, 150 mM NaCl) supplemented
with 1% Triton-X 100, 1 mM PMSF and a protease inhibitor
E, HEK293T cells expressing the indicated plasmids were subjected to immunoprecipitation and then immunoblotted with the indicated antibodies.
F, HEK293T cells were transfected with the indicated plasmids. Twenty-four hours after transfection, cell lysates were subjected to
immunoprecipitation and then immunoblotted with the indicated antibodies. G and H, Raw264.7 cells transfected with the indicated plasmids
(G) or siRNAs (H) were stimulated with R837 for the indicated time periods. The cell lysates were immunoblotted with an anti-TANK antibody. 5M,
K229, 233, 280, 302 and 306R.
doi:10.1371/journal.ppat.1002057.g005
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PLoS Pathogens | www.plospathogens.org 10 May 2011 | Volume 7 | Issue 5 | e1002057Figure 6. MARCH5 modulates the auto-ubiquitination of TRAF6. A, Raw264.7 cells were transfected with the negative control (N.C.) or TANK
siRNA. Then the cells were treated with R837 (10 mg/ml) for the indicated time periods. Induction of IL6 and TNFa mRNA was measured by
quantitative PCR. B, Raw264.7 cells were transfected with the indicated siRNAs and then stimulated with R837 (10 mg/ml) for the indicated time
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incubated with the appropriate antibody for four hours to
overnight at 4uC. Two hours after adding protein A/G agarose,
the immuno-precipitates were extensively washed with lysis buffer
and eluted with SDS loading buffer by boiling for 3 min.
For immuno-blot analysis, the samples were resolved by SDS-
PAGE and transferred to a PVDF membrane (Millipore).
Immunoblotting was probed with indicated antibodies. The
proteins were visualized by using a NBT/BCIP Western blotting
system (Promega) or a SuperSignal West Pico chemiluminescence
ECL kit (Pierce).
Ni-NTA pulldown analysis
For Ni-NTA pulldown analysis, cells were washed with PBS and
then lysed in His-Lysis Buffer (50 mM Tris-Cl. pH 7.4, 6M Urea).
20 mL Ni-NTA agarose beads (Qiagen) were then added into the
post-centrifuged lysates and rotated for four hours at 4uC. After
extensively washing with His-Lysis Buffer, the precipitates were
boiled with SDS loading buffer and then subjected to SDS-PAGE
followed by immuno-blot analysis.
Reporter assays
Cells were seeded in 12-well plates and transfected with reporter
gene plasmids combined with siRNAs and other constructs as
indicated. The total amount of DNA was kept constant by
supplementing with empty vectors. pTK-Renilla was cotransfected
to normalize transfection efficiency. Luciferase activity was
analyzed with the Dual Luciferase Reporter Assay System
(Promega).
Real-time RT-PCR
Total RNA was extracted using TRIzol reagent (Invitrogen)
according to the manufacturer’s instruction. Reverse transcription
of purified RNA was performed using oligonucleotide dT primer.
The quantifications of gene transcripts were performed by real-
time PCR using Power SYBR GREEN PCR MASTER MIX
(ABI). All values were normalized to the level of b-actin mRNA.
The primers used are as follows:
b-actin sense (5-AAAGACCTCTATGCCAACAC-3),
b-actin antisense (5- TCGTACTCCTGCTTGCTGAT-3);
IL6 sense (5- GAGAGGAGACTTCACAGAGGATAC-3),
IL6 antisense (5- GTACTCCAGAAGACCAGAGG-3);
TNFa sense (5- GACACCATGAGCACAGAAAG-3),
TNFa antisense (5- GAGTAGACAAGGTACAACCC-3);
ISG15 sense(5- GACACCATGAGCACAGAAAG-3),
ISG15 antisense (5- GAGTAGACAAGGTACAACCC-3).
RNA interference
Chemically synthesized 21-nucleotide siRNA duplexes were
obtained from Gene-Pharma and transfected using Lipofectamine
2000 (Invitrogen) according to the manufacturer’s instructions.
RNA oligonucleotides used in this study are as follows:
NC: 5-UUCUCCGAAGGUGUCACGU-3;
si-MARCH5 369#: 5-GGUUGUAGGCCAUAAAGAATT-3;
si-MARCH5 582#: 5-AGCUGAAGCUAACCCUUUATT-3;
si-hMARCH5: 5-GGGUGGAAUUGCGUUUGUUTT-3;
si-TANK: 5-GACUUUCUGGGACCUUAAATT-3.
Confocal microscopy
Cells were fixed with 4% paraformaldehyde, permeabilized with
0.1% Triton X-100, blocked with 1% bovine serum albumin and
stained with the indicated primary antibodies followed by FITC-
conjugated secondary antibody (Jackson Immuno-Research Lab-
oratories). Nuclei were counterstained with DAPI (Sigma-Aldrich).
For mitochondria staining, living cells were incubated with
300 nM Mito Tracker Red (Invitrogen) for 30 min at 37uC.
Slides were mounted by Aqua-Poly/Mount (Polysciences). Imag-
ing of the cells was carried out using Leica laser scanning confocal
microscopy.
Cell cycle Analysis
Preparations of cell suspensions for cell cycle analysis were
performed as previously described [47]. Briefly, cells were
trypsinized and fixed in ice-cold 70% ethanol at 4uC. After being
washed with PBS twice, DNA was stained with 20 mg/mL
propidium iodide (Sigma-Aldrich) in the presence of 200 mg/mL
RNase A (Fermentas). Data were acquired on a FACSCalibur (BD
Biosciences) and analyzed using CellQuest (BD Biosciences) and
FlowJo (TreeStar Inc.).
In vitro ubiquitination assay
For the synthesis of polyUb chains, purified MBP-MARCH5-
NT (0.1 mM) was mixed with E1 (50 nM), E2 (0.3 mM), ubiquitin
or ubiquitin mutants (0.1 mM) (Boston Biochem) in a reaction
buffer containing 50 mM Tris–HCl, pH 7.5, 5 mM MgCl2,
2 mM ATP, 2 mM DTT. The reaction was carried out at 30uC
for 90 min and then resolved by SDS-PAGE. Ubiquitinated
products were detected by immunoblotting with a Ub-specific
antibody (P4D1).
Measurement of cytokines
Concentrations of cytokines in culture supernatants were
measured by ELISA kits (R&D Systems) according to the
manufacturer’s instructions.
Sub-cellular fractionation
HEK293T cells were washed with cold PBS and lysed by
douncing in homogenization buffer (buffer H: 210 mM sucrose,
70 mM mannitol, 1 mM EDTA, 1 mM EGTA, 1.5 mM MgCl2,
10 mM Hepes (pH 7.2), protease inhibitor cocktail). The
homogenate was centrifuged at 5006g for 10 min, and the pellet
(P1) was saved as crude nuclei. The supernatant (S1) was
centrifuged at 5,0006g for 10 min to precipitate mitochondria
(P5). The whole cell and fractions of P5 and S5 were lysed in lysis
buffer (50 mM Tris-HCl. pH 7.4, 150 mM NaCl, 1 mM EDTA,
periods. Cell lysates were subjected to immunoprecipitation and then immunoblotted with the indicated antibodies. C, Raw264.7 cells were
transfected with the empty vector or the indicated plasmids and then stimulated with R837 (10 mg/ml) for 5 minutes. Cell lysates were subjected to
immunoprecipitation and then immunoblotted with the indicated antibodies. D, Raw264.7 cells were transfected with the indicated siRNAs and then
stimulated with R837 (10 mg/ml) for 7.5 minutes. Cell lysates were subjected to immunoprecipitation and then immunoblotted with the indicated
antibodies. E, The indicated siRNAs were transfected into Raw264.7 cells. Induction of IL6 and TNFa mRNA was measured by quantitative PCR after
R837 (10 mg/ml) stimulation. Data from A and E are presented as means 6 S.D. from three independent experiments. *, P,0.05; **, P,0.01.
doi:10.1371/journal.ppat.1002057.g006
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PLoS Pathogens | www.plospathogens.org 12 May 2011 | Volume 7 | Issue 5 | e1002057Figure 7. Mislocalization of MARCH5 impairs its function. A, Schematic diagram of wild-type MARCH5 (MARCH5 WT), its mislocalization
mutants and the C-terminal transmembrane domain truncation (D105-246 a.a.) (MARCH5-DM); (RING, RING finger domain; TM, transmembrane
domain; NLS, nuclear localization sequence). B, HA-MARCH5, HA-MARCH5-CAAX and HA-MARCH5-NLS were transfected into HEK293T cells
individually, which were then stained with an anti-HA antibody and imaged by confocal microscopy. The mitochondria were stained with
MitoTracker. C, HEK293T cells were transfected with the indicated constructs. Then, equal amounts of cell lysates were immunoprecipitated with an
anti-HA antibody. The immunoprecipitates were immunoblotted with an anti-Flag antibody. D and E, HEK293T cells were transfected with the
indicated plasmids. Twenty-four hours after transfection, cell lysates were subjected to Ni-NTA pulldown (Ni PD) (D) or immunoprecipitation (E) and
then immunoblotted with the indicated antibodies. F and G, Equal amounts of the indicated Myc-tagged MARCH5 constructs were transfected into
Raw264.7 cells. Induction of IL6 and TNFa mRNA by R837 (10 mg/ml) (F) or LPS (100 ng/ml) (G) stimulation was measured by quantitative PCR. Data
from F and G are presented as means 6 S.D. from three independent experiments. *, P,0.05; **, P,0.01. WT, wild type MARCH5; CAAX, MARCH5-
CAAX; NLS, MARCH5-NLS.
doi:10.1371/journal.ppat.1002057.g007
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immunoblot analysis.
Statistics
Student’s t test was used for the statistical analysis of two
independent treatments. For all tests, a P value of ,0.05 was
considered statistically significant.
Accession numbers
The GenBank (http://www.ncbi.nlm.nih.gov/Genbank) acces-
sion numbers for the genes and gene products discussed in this
paper are:
MARCH5 (NM_027314, NP_081590), TANK (NM_00116-
4071.1, NP_001157543.1), GIDE (NM_026689.3, NP_080965.2),
TRAF6 (NM_004620.2, NP_004611.1), TRAF3 (NM_145725.2,
NP_663777.1), NEMO (NM_001099857.1, NP_001093327.1),
MAVS (NM_020746.4, NP_065797.2), RIG-I (NM_014314.3,
NP_055129.2), TRIF (NM_182919.2, NP_891549.1), MyD88
(NM_002468.4, NP_002459.2), IRAK1 (NM_001025242.1, NP_
001020413.1).
Supporting Information
Figure S1 MARCH5 potentiates the expression of pro-inflam-
matory cytokines. A and B, Raw264.7 cells were transfected with
the indicated plasmids. After R837 (10 mg/ml) (A) or LPS
(100 ng/ml) (B) stimulation, IL6 and TNFa production was
determined by ELISA. C and D, Raw264.7 cells were transfected
with the indicated siRNAs. TNFa and IL-6 production was
measured by ELISA after R837 (10 mg/ml) (C) or LPS (100
ng/ml) (D) treatment. Data from A–D are presented as means 6
S.D. from three independent experiments. *, P,0.05; **, P,0.01.
N.D., not detected.
(TIF)
Figure S2 Ectopic expression of MARCH5 displays no effect on
cell cycling. A and B, Representative DNA histogram of PI
fluorescence in cells, as assessed by FACS. Equal amounts of the
indicated constructs were transfected into Raw264.7 cells.
Twenty-four hours after transfection, cells were stimulated with
R837 (10 mg/ml) (A) or LPS (100 ng/ml) (B) before cell cycle
analysis was performed. C, the ratio of cells in G0–G1 phase, S
phase and G2-M phase of the cell cycle was measured by FACS
and analyzed by FlowJo software. Data are presented as means 6
S.D. from three independent experiments.
(TIF)
Figure S3 Knockdown of MARCH5 does not affect cell cycling.
A and B, Representative DNA histogram of PI fluorescence in
cells, as assessed by FACS. Raw264.7 cells were transfected with
the indicated siRNAs. Cell cycle analysis was performed after
R837 (10 mg/ml) (A) or LPS (100 ng/ml) (B) stimulation. C, Ratio
of cells in G0–G1 phase, S phase and G2-M phase of the cell cycle
was measured by FACS and analyzed by FlowJo software. Data
are presented as means 6 S.D. from three independent
experiments.
(TIF)
Figure S4 TANK is partially co-localized with mitochondria
upon TLR7 stimulation. A and B, After stimulation by R837 or
LPS, RAW264.7 cells were immunostained with anti-TANK (A)
or anti-TRAF6 (B) antibodies as indicated, and then imaged by
confocal microscopy. The mitochondria were stained with
MitoTracker. Arrows indicate representative co-localization be-
tween TANK and mitochondria.
(TIF)
Figure S5 MARCH5 facilitates the assembly of both K48- and
K63-Linked polyUb Chains in vitro. A, Synthesis of polyUb chains
by MARCH5-NT (MARCH5 1-96a.a.) but not MARCH5-NT
C2A or MARCH5-NT DRING. The ubiquitination reaction
contains E1, E2, Ub, and MARCH5-NT or MARCH5 RING-
finger mutants (MARCH5-NT C2A and MARCH5-NT DRING)
as indicated. PolyUb chains were detected by immunoblotting
with a Ub-specific antibody. B and C, MARCH5-NT catalyzed
the formation of both K63- (B) and K48-linked (C) polyUb chains.
K48 and K63: all lysines on Ub are mutated to arginine except for
K48 or K63.
(TIF)
Figure S6 TANK(5M) mutant could interact with MARCH5.
HEK293T cells were cotransfected with the indicated constructs.
Then, equal amounts of cell lysates were immunoprecipitated with
an anti-Flag antibody. The immunoprecipitates were immuno-
blotted with an anti-HA antibody.
(TIF)
Figure S7 MARCH5 does not catalyze the poly-ubiquitination
of RIG-I, MAVS, or TRAF3. HEK293T cells were transfected
with the indicated plasmids. Twenty-four hours after transfection,
cell lysates were subjected to immunoprecipitation and then
immunoblotted with the indicated antibodies.
(TIF)
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